Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$9,473,419
+$738,744 QoQ
Shares Held
26,161
+5.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#566
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simmons Bank holds $67,934,657 across 11 Drug Manufacturers - General names. AMGN ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
51,844 | $13,046,023 | |
| 2 | LLY |
ELI LILLY & Co
|
10,864 | $13,030,606 | |
| 3 | AMGN |
Amgen Inc
This page
|
26,161 | $9,473,419 | |
| 4 | MRK |
Merck & Co., Inc.
|
70,419 | $9,048,841 | |
| 5 | JNJ |
Johnson & Johnson
|
35,136 | $8,923,488 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
37,464 | $4,733,201 | |
| 7 | PFE |
Pfizer Inc
|
125,117 | $3,012,817 | |
| 8 | GSK |
GSK plc
|
57,449 | $3,011,475 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,473,419 | 26,161 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $8,734,675 | 24,825 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $7,890,788 | 24,108 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $6,351,192 | 22,506 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $6,345,046 | 22,725 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $7,023,270 | 22,543 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $5,984,293 | 22,960 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $7,436,928 | 23,081 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $7,151,042 | 22,887 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $6,707,676 | 23,592 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,591,049 | 22,884 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $7,322,096 | 27,244 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $5,885,305 | 26,508 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $6,558,918 | 27,131 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $6,731,725 | 25,631 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $5,545,514 | 24,603 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $5,696,382 | 23,413 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $5,305,046 | 21,938 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $4,642,480 | 20,636 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $4,264,695 | 20,055 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $4,916,437 | 20,170 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $4,351,436 | 17,489 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,573,645 | 15,543 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,252,485 | 12,797 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,027,970 | 12,838 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,457,290 | 12,121 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||